ReviewJAMA internal medicine2019

An Overview of Cancer Drugs Approved by the US Food and Drug Administration Based on the Surrogate End Point of Response Rate.

Emerson Y Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.